Compare PCVX & PPC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | PCVX | PPC |
|---|---|---|
| Founded | 2013 | 1946 |
| Country | United States | United States |
| Employees | N/A | 52100 |
| Industry | Biotechnology: Pharmaceutical Preparations | Meat/Poultry/Fish |
| Sector | Health Care | Consumer Staples |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 8.6B | 8.4B |
| IPO Year | 2020 | 1997 |
| Metric | PCVX | PPC |
|---|---|---|
| Price | $54.29 | $27.56 |
| Analyst Decision | Strong Buy | Hold |
| Analyst Count | 4 | 3 |
| Target Price | ★ $88.25 | $41.33 |
| AVG Volume (30 Days) | ★ 1.3M | 1.3M |
| Earning Date | 05-07-2026 | 04-29-2026 |
| Dividend Yield | N/A | ★ 6.74% |
| EPS Growth | N/A | ★ N/A |
| EPS | N/A | ★ 0.43 |
| Revenue | N/A | ★ $18,497,553,000.00 |
| Revenue This Year | N/A | $2.46 |
| Revenue Next Year | N/A | $1.83 |
| P/E Ratio | ★ N/A | $66.72 |
| Revenue Growth | N/A | ★ 3.46 |
| 52 Week Low | $29.00 | $28.28 |
| 52 Week High | $65.00 | $51.45 |
| Indicator | PCVX | PPC |
|---|---|---|
| Relative Strength Index (RSI) | 40.89 | 24.17 |
| Support Level | $52.04 | N/A |
| Resistance Level | $56.04 | $39.55 |
| Average True Range (ATR) | 2.65 | 1.25 |
| MACD | -0.60 | -0.30 |
| Stochastic Oscillator | 43.34 | 0.16 |
Vaxcyte Inc is a clinical-stage vaccine company engineering high-fidelity vaccines to protect humankind from the consequences of bacterial diseases. It uses the XpressCF cell-free protein synthesis platform to develop potentially superior and novel conjugate and protein vaccine candidates for adult and pediatric indications. The company's product pipeline includes: VAX-31, VAX-24, and VAX-XL PCV vaccine candidates; VAX-A1, a Novel Group A Strep Vaccine; and VAX-GI, a Novel Shigella Vaccine, among others, in their different stages of development.
Pilgrim's Pride is the second-largest poultry producer in the US (59% of 2024 sales), the UK (29% including other European sales), and Mexico (12%). Its UK and European arm also includes pork operations from the 2019 acquisition of Tulip. Pilgrim's sells to chain restaurants, food processors, food distributors, and retail chains. Most of its US and Mexican sales come from fresh chicken, while prepared chicken and pork constitute most of its UK and European sales. JBS owns more than 80% of Pilgrim's Pride's outstanding shares, though it failed to acquire the remaining stake in 2021 after a special board committee deemed JBS's offer undervalued Pilgrim's Pride.